Invesco Ltd. - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 105 filers reported holding CARIBOU BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$326,780
+16.6%
68,364
+3.7%
0.00%
Q2 2023$280,271
-24.0%
65,946
-5.1%
0.00%
Q1 2023$368,849
+172.7%
69,463
+222.5%
0.00%
Q4 2022$135,277
-95.9%
21,541
-93.2%
0.00%
-100.0%
Q3 2022$3,324,000
+3224.0%
315,052
+1611.4%
0.00%
Q2 2022$100,000
-9.1%
18,409
+52.0%
0.00%
Q1 2022$110,00012,1130.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q1 2022
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 674,196$6,189,0007.17%
72 Investment Holdings, LLC 474,067$4,352,0004.76%
Velan Capital Investment Management LP 210,695$1,934,0001.80%
PFM Health Sciences, LP 4,370,545$40,122,0001.50%
Monashee Investment Management LLC 470,000$4,315,0001.25%
Avidity Partners Management LP 2,819,067$25,879,0000.54%
Rokos Capital Management LLP 849,334$7,899,0000.37%
Green Alpha Advisors, LLC 49,674$456,0000.31%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 181,304$1,664,0000.25%
Tekla Capital Management LLC 699,377$6,420,0000.22%
View complete list of CARIBOU BIOSCIENCES INC shareholders